|Bid||53.92 x 900|
|Ask||53.93 x 900|
|Day's Range||53.63 - 54.64|
|52 Week Range||41.03 - 56.88|
|Beta (5Y Monthly)||1.32|
|PE Ratio (TTM)||N/A|
|Earnings Date||Feb 05, 2020|
|Forward Dividend & Yield||1.92 (3.54%)|
|Ex-Dividend Date||Dec 29, 2019|
|1y Target Est||51.60|
Rating Action: Moody's affirms Cardinal Health's Baa2 senior unsecured rating; outlook changed to negative. Global Credit Research- 17 Jan 2020. New York, January 17, 2020-- Moody's Investors Service affirmed ...
Shareholder rights law firm Robbins LLP is investigating whether certain officers and directors of Cardinal Health, Inc. (NYSE: CAH) breached their fiduciary duties. Cardinal Health operates as an integrated healthcare services and products company.
Oklahoma Attorney General Mike Hunter on Monday brought a lawsuit against three distributors of opioids after winning a lawsuit against one drug manufacturer and reaching pretrial settlements in other cases.
Cardinal Health (CAH) is gaining from diversified product portfolio and robust pharmaceutical segment. However, integration risks remain a concern.
We are still in an overall bull market and many stocks that smart money investors were piling into surged in 2019. Among them, Facebook and Microsoft ranked among the top 3 picks and these stocks gained more than 57% each. Hedge funds' top 3 stock picks returned 45.7% last year and beat the S&P 500 […]
Cardinal (CAH) has been upgraded to a Zacks Rank 2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Surmodics (SRDX) is gaining from continued strength at Medical Devices unit and persistent efforts to boost R&D functionalities. However, weak performance at Surmodics' IVD unit remains a concern.
Cardinal Health (NYSE: CAH) plans to release second quarter financial results for its fiscal year 2020 on Feb. 6 prior to the opening of trading on the New York Stock Exchange. The company will webcast a discussion of these results beginning at 8:30 a.m. Eastern.
Intuitive Surgical (ISRG) continues to benefit from da Vinci surgical system, strong global foothold and solid recurring revenue base. However, margin contraction remains a concern.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Moody's Investors Service, ("Moody's") downgraded Owens & Minor Inc.'s Corporate Family Rating (CFR) to B3 from B2 and the Probability of Default Rating (PDR) to B3-PD from B2-PD. Moody's also downgraded the ratings on the senior secured credit facilities and notes to B3 from B2. Concurrently, Moody's downgraded the Speculative Grade Liquidity Rating, to SGL-4 from SGL-3, signifying weak liquidity.
AmerisourceBergen Corp. is moving forward with an expansion to its pharmaceutical distribution facility near Rickenbacker International Airport even though the city of Columbus has indefinitely delayed an incentive.
SAN DIEGO, Dec. 17, 2019 -- The Shareholders Foundation, Inc. announces that a lawsuit is pending for certain investors in Cardinal Health, Inc. (NYSE: CAH) shares. Investors,.
Cardinal (CAH) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank 2 (Buy).
Amid an overall bull market, many stocks that smart money investors were collectively bullish on surged through the end of November. Among them, Facebook and Microsoft ranked among the top 3 picks and these stocks gained 54% and 51% respectively. Our research shows that most of the stocks that smart money likes historically generate strong […]